M
Masashi Fujita
Researcher at Osaka University
Publications - 86
Citations - 3874
Masashi Fujita is an academic researcher from Osaka University. The author has contributed to research in topics: Stent & Heart failure. The author has an hindex of 27, co-authored 86 publications receiving 3497 citations.
Papers
More filters
Journal ArticleDOI
Prolonged Endoplasmic Reticulum Stress in Hypertrophic and Failing Heart After Aortic Constriction Possible Contribution of Endoplasmic Reticulum Stress to Cardiac Myocyte Apoptosis
Ken-ichiro Okada,Tetsuo Minamino,Yoshitane Tsukamoto,Yulin Liao,Osamu Tsukamoto,Seiji Takashima,Akio Hirata,Masashi Fujita,Yoko Nagamachi,Takeshi Nakatani,Chikao Yutani,Kentaro Ozawa,Satoshi Ogawa,Hitonobu Tomoike,Masatsugu Hori,Masafumi Kitakaze +15 more
TL;DR: Findings suggest that pressure overload by TAC induces prolonged ER stress, which may contribute to cardiac myocyte apoptosis during progression from cardiac hypertrophy to failure.
Journal ArticleDOI
Short-term statin therapy improves cardiac function and symptoms in patients with idiopathic dilated cardiomyopathy.
TL;DR: Short-term statin therapy improves cardiac function, neurohormonal imbalance, and symptoms associated with idiopathic dilated cardiomyopathy and suggest that statins may have therapeutic benefits in patients with heart failure irrespective of serum cholesterol levels or atherosclerotic heart disease.
Journal ArticleDOI
Metformin prevents progression of heart failure in dogs: role of AMP-activated protein kinase.
Hideyuki Sasaki,Hiroshi Asanuma,Masashi Fujita,Hiroyuki Takahama,Masakatsu Wakeno,Shin Ito,Akiko Ogai,Masanori Asakura,Jiyoong Kim,Tetsuo Minamino,Seiji Takashima,Shoji Sanada,Masaru Sugimachi,Kazuo Komamura,Naoki Mochizuki,Masafumi Kitakaze +15 more
TL;DR: Metformin attenuated oxidative stress–induced cardiomyocyte apoptosis and prevented the progression of heart failure in dogs, along with activation of AMPK, suggesting metformin may be a potential new therapy for heart failure.
Journal ArticleDOI
Natriuretic Peptides Enhance the Production of Adiponectin in Human Adipocytes and in Patients With Chronic Heart Failure
Osamu Tsukamoto,Masashi Fujita,Mahoto Kato,Satoru Yamazaki,Yoshihiro Asano,Akiko Ogai,Hidetoshi Okazaki,Mitsutoshi Asai,Yoko Nagamachi,Norikazu Maeda,Yasunori Shintani,Tetsuo Minamino,Masanori Asakura,Ichiro Kishimoto,Tohru Funahashi,Hitonobu Tomoike,Masafumi Kitakaze +16 more
TL;DR: Natriuretic peptides enhance adiponectin production by human adipocytes in vitro and even in patients with CHF, which might have a beneficial effect on cardiomyocytes in patients receiving recombinant natriureic peptide therapy for heart failure.
Journal ArticleDOI
Importance of the angiosome concept for endovascular therapy in patients with critical limb ischemia
Osamu Iida,Shinsuke Nanto,Masaaki Uematsu,Kuniyasu Ikeoka,Shin Okamoto,Tomoharu Dohi,Masashi Fujita,Hiroto Terashi,Seiki Nagata +8 more
TL;DR: Acquiring direct flow based on the angiosome concept is important for limb salvage by EVT in patients with CLI, and it is significantly higher in the direct group than in the indirect group for up to 4 years after the procedure.